Aarti Drugs
add_icon

Aarti Drugs

428.50
-8.50
(-1.95%)
Market Cap
3,910.92 Cr
PE Ratio
20.86
Volume
1,73,089.00
Day High - Low
444.00 - 426.15
52W High-Low
534.55 - 318.95
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,910.92 Cr
EPS
21.36
PE Ratio
20.86
PB Ratio
2.57
Book Value
169.70
EBITDA
311.60
Dividend Yield
0.46 %
Industry
Healthcare
Return on Equity
12.58
Debt to Equity
0.41
Analyst Rating and Forecast
- By Refinitiv from1 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+100.00 %
+100.00 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Aarti Drugs Limited has scheduled its 41st Annual General Meeting for September 26, 2026. The meeting will be held via video conferencing to transact business for FY26. Shareholders can vote electronically.
neutral
Aarti Drugs Ltd schedules board meeting for August 27, 2026 to approve Performance Stock Option Plan 2026. Trading window closes from August 25 to August 29.
positive
Aarti Drugs reported a 19% YoY revenue rise to ₹703.6 crore in Q1FY27, driven by API price hikes. EBITDA grew 30% to ₹96.9 crore with margin expansion of 120 bps.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,840.00
#1 4,41,477.63
36.91
#1 61,673.90
12.69
#1 11,565
26.53
34.00
9,322.00
2,47,469.81
85.36
11,067.00
13.95
2,568
65.50
63.65
4,965.50
1,88,871.66
86.95
13,886.20
20.34
2,138
3.28
52.16
1,119.10
1,12,607.65
24.28
27,657.90
17.64
5,026
-34.90
45.64
1,366.00
1,10,351.67
33.22
29,044.60
2.24
3,870
-39.18
35.27
1,969.00
1,06,297.76
95.94
6,867.80
22.01
890
#1 123.93
68.28
1,165.50
97,280.68
29.91
35,058.60
3.90
4,158
-69.10
47.72
1,679.80
96,651.98
25.88
34,145.20
5.56
3,503
25.21
57.04
2,095.00
95,790.22
#1 17.09
29,038.90
#1 26.75
5,356
16.00
28.17
2,280.00
94,163.08
44.87
14,636.40
14.85
1,938
29.13
37.57
Growth Rate
Revenue Growth
6.84 %
Net Income Growth
15.94 %
Cash Flow Change
3.66 %
ROE
2.44 %
ROCE
-9.33 %
EBITDA Margin (Avg.)
-3.88 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
283
273
265
314
292
316
291
299
258
319
336
332
375
348
380
464
406
478
474
459
546
578
533
503
582
580
642
697
622
688
665
743
662
642
608
621
557
600
569
679
591
653
603
721
704
Expenses
240
230
226
269
244
265
247
253
223
267
282
274
322
300
328
403
351
409
410
378
411
462
425
421
500
506
545
608
555
614
593
649
577
565
536
534
490
531
495
583
516
569
547
625
607
EBITDA
44
42
40
45
48
51
43
46
36
53
54
57
54
47
52
61
55
69
64
81
135
117
108
82
81
74
97
89
67
74
72
94
85
77
72
87
66
69
74
95
74
84
56
97
97
Operating Profit %
15 %
16 %
15 %
14 %
16 %
16 %
15 %
16 %
14 %
16 %
16 %
17 %
14 %
14 %
14 %
12 %
13 %
14 %
13 %
16 %
25 %
20 %
20 %
16 %
14 %
13 %
14 %
12 %
11 %
11 %
11 %
13 %
13 %
12 %
12 %
14 %
12 %
11 %
11 %
14 %
13 %
13 %
9 %
13 %
14 %
Depreciation
9
9
9
9
10
10
10
9
10
10
10
10
10
11
11
11
12
12
12
13
12
13
13
12
12
13
13
13
13
13
13
13
13
13
13
14
13
14
14
15
15
16
18
18
19
Interest
10
11
11
12
10
9
9
9
9
8
9
9
9
10
11
10
9
9
8
8
7
7
5
4
4
5
5
6
7
9
9
9
9
8
8
9
9
9
9
9
9
8
9
8
9
Profit Before Tax
25
23
23
25
29
33
24
31
17
35
35
38
34
27
31
40
34
48
43
61
116
97
90
65
65
56
79
71
48
53
50
73
64
56
52
64
44
46
51
71
51
60
29
70
69
Tax
8
7
6
6
9
11
6
9
5
11
12
14
10
9
10
12
11
16
15
2
31
22
22
14
16
14
20
15
13
14
13
17
16
17
15
17
11
11
14
8
-3
15
-12
15
19
Net Profit
17
16
17
19
20
22
18
22
11
24
23
24
23
18
21
27
23
32
28
59
85
75
68
52
49
43
58
55
35
39
37
56
48
40
37
47
33
35
37
63
54
45
41
55
50
EPS in ₹
7.18
6.49
7.03
7.68
8.21
9.11
7.56
8.70
4.77
9.89
9.78
9.97
9.82
7.65
8.86
12.06
9.56
13.87
11.92
25.26
9.17
8.08
7.30
5.54
5.25
4.60
6.29
5.97
3.76
4.18
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
4.95
4.44
6.05
5.49

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
2,575
2,815
Fixed Assets
449
493
581
602
625
644
665
690
676
811
866
1,086
Current Assets
526
565
571
737
784
900
1,057
1,393
1,492
1,321
1,338
1,468
Capital Work in Progress
16
34
14
28
33
12
19
77
210
261
330
214
Investments
0
0
12
11
12
13
17
20
19
20
22
27
Other Assets
537
575
584
748
785
907
1,064
1,422
1,516
1,340
1,356
1,488
Total Equity & Liabilities
1,002
1,102
1,191
1,389
1,456
1,577
1,766
2,208
2,421
2,432
2,575
2,815
Current Liabilities
483
501
494
622
591
623
595
940
933
796
837
922
Non Current Liabilities
211
244
297
312
321
301
257
232
296
355
368
344
Total Equity
308
357
400
455
543
653
913
1,036
1,193
1,282
1,369
1,549
Reserve & Surplus
284
333
376
432
520
629
820
944
1,100
1,190
1,278
1,458
Share Capital
24
24
24
24
24
23
93
93
93
92
91
91

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-1
1
-0
0
1
2
2
13
-14
-1
-2
3
Investing Activities
-107
-99
-107
-74
-62
-33
-72
-150
-164
-224
-165
-173
Operating Activities
105
133
175
70
143
251
155
70
133
359
245
254
Financing Activities
2
-33
-68
4
-80
-215
-81
92
17
-136
-82
-77

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
60.20 %
60.14 %
60.12 %
59.99 %
59.83 %
59.98 %
59.77 %
59.66 %
59.58 %
58.70 %
58.56 %
57.47 %
57.13 %
55.67 %
55.64 %
55.38 %
55.48 %
55.22 %
54.72 %
55.03 %
55.03 %
54.43 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.33 %
2.10 %
2.56 %
2.96 %
2.50 %
2.28 %
2.25 %
2.26 %
2.69 %
2.15 %
1.58 %
1.52 %
DIIs
1.59 %
1.97 %
2.09 %
2.28 %
2.69 %
2.76 %
3.16 %
3.90 %
4.09 %
4.71 %
5.32 %
5.26 %
5.99 %
7.35 %
7.84 %
8.77 %
9.70 %
9.94 %
9.90 %
10.12 %
10.22 %
10.29 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
31.86 %
32.32 %
32.68 %
32.85 %
32.02 %
32.16 %
26.66 %
25.98 %
25.72 %
25.34 %
24.65 %
25.84 %
25.11 %
24.75 %
24.80 %
24.32 %
23.51 %
23.69 %
23.58 %
23.43 %
23.72 %
24.12 %
Others
6.36 %
5.57 %
5.11 %
4.89 %
5.46 %
5.10 %
10.41 %
10.46 %
10.61 %
11.25 %
9.14 %
9.33 %
9.20 %
9.27 %
9.21 %
9.24 %
9.06 %
8.89 %
9.11 %
9.27 %
9.46 %
9.63 %
No of Share Holders
1,73,704
1,77,992
1,83,344
1,95,469
1,89,607
1,86,674
1,80,303
1,73,283
1,69,090
1,62,409
1,67,446
1,70,414
1,57,547
1,50,218
1,90,281
1,76,006
1,69,761
1,60,260
1,52,252
1,48,363
1,44,946
1,43,476

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1 1 1 2 2.5 1 1 1 1 2
Dividend Yield (%) 0.79 0.63 0.8 0.29 0.58 0.3 0.23 0.29 0.31 0.47

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2026 426.70 428.35
01 Oct 2020 BONUS Bonus
3:1
30 Sept 2020 741.84 771.30
10 Feb 2022 DIVIDEND Dividend
₹ 1.00 /share
09 Feb 2022 497.60 525.00
08 Feb 2023 DIVIDEND Dividend
₹ 1.00 /share
08 Feb 2023 406.10 393.45
09 Aug 2023 BUYBACK Buyback
900
04 Aug 2023 562.35 576.15
06 Feb 2024 DIVIDEND Dividend
₹ 1.00 /share
06 Feb 2024 535.45 519.95
11 Sept 2024 BUYBACK Buyback
900
05 Sept 2024 524.85 539.85
20 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2024 582.80 518.60
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Oct 2024 504.35 488.25
29 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Jan 2025 424.35 390.15
04 Feb 2025 DIVIDEND Dividend
₹ 1.00 /share
04 Feb 2025 390.15 423.40
06 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 May 2025 351.65 355.05
18 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Jul 2025 480.75 515.75
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2025 469.55 513.45
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 502.00 488.90
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2026 370.05 383.55
09 Feb 2026 DIVIDEND Dividend
₹ 2.00 /share
09 Feb 2026 383.55 374.65
15 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2026 397.65 362.95
31 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jul 2026 408.90 412.80

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Business Responsibility and Sustainability Reporting (BRSR)Sep 02, 2026
Notice Of 41St Annual General Meeting Of The CompanySep 02, 2026
Reg. 34 (1) Annual Report.Sep 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2026
Board Meeting Outcome for Approval Of Aarti Drugs Limited Performance Stock Option Plan 2026Aug 27, 2026
Closure of Trading WindowAug 24, 2026
Board Meeting Intimation for Aarti Drugs Limited - Performance Stock Option Plan 2026Aug 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 14, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")Aug 10, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2026
Revocation Of Closure Order By GPCB Related To Plant Located At SayakhaAug 01, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 31, 2026
Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2026Jul 31, 2026
Financial Results For The Quarter Ended June 30 2026Jul 31, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2026
Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30 2026Jul 24, 2026
Closure Directions By GPCBJul 18, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 27, 2026
Closure of Trading WindowJun 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 16, 2026
Transfer Of Equity Shares Of The Company To IEPFJun 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 05, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 18, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 18, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 16, 2026
Re-Appointment Of Cost Auditor And Internal AuditorMay 15, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 15 2026May 15, 2026
Financial Results For The Quarter And Year Ended March 31 2026May 15, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31 2026May 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 06, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Credit RatingMar 24, 2026
Disclosure Under Regulation 30 Of SEBI Listing RegulationsMar 16, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMar 07, 2026

Technical Indicators

RSI(14)
Neutral
54.97
ATR(14)
Volatile
13.83
STOCH(9,6)
Neutral
51.83
STOCH RSI(14)
Neutral
68.33
MACD(12,26)
Bullish
0.55
ADX(14)
Strong Trend
28.80
UO(9)
Bearish
37.32
ROC(12)
Uptrend And Accelerating
2.51
WillR(14)
Neutral
-45.52